PROFESSIONAL RESOURCES

This section is designed to provide important information regarding reimbursement, the IMBRUVICA® Dose Exchange Program, specialty pharmacies, and other product information.

Such information may be subject to continual change and interpretation. It is provided for informational purposes only and does not guarantee coverage or payment. It is always the provider's responsibility to determine and submit appropriate codes and modifiers based on the services rendered and the provider's medical judgment. Providers should contact the payer for coding and billing guidance.

Medical chart icon

IMBRUVICA® (ibrutinib) Diagnosis Codes

Indication1

IMBRUVICA® is a once-daily oral therapy indicated for the treatment of adult patients with:

  • Waldenström’s macroglobulinemia (WM).

WM ICD-10-CM Code in Detail

This is a potential code for consideration by you and your office.

WM diagnosis code2

C88.0Waldenström macroglobulinemia

Abbreviations

ICD-10-CM=International Classification of Diseases, Tenth Revision, Clinical Modification.

References

1IMBRUVICA® (ibrutinib) Prescribing Information. 22022 Code Tables, Tabular and Index. Updated 02/01/2022.